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Intra-Articular Injections for Analgesia in Knee Osteoarthritis: 
“Placebo” Normal Saline vs Corticosteroids
Knee Osteoarthritis 
Osteoarthritis (OA) is the most common form of arthritis, 
currently affecting an estimated 31 million Americans. 
Osteoarthritis is a degenerative disease of the joint spaces and is 
commonly thought of as a “wear and tear” disease. There are, in 
fact, more contributing processes as inflammatory factors have 
been shown to play a role in disease initiation and progression. 
Osteoarthritis is one of the most common causes of disability in 
the elderly, with pain, instability and loss of range of motion 
being the most common presenting symptoms in those affected.2
Risk Factors for developing Knee OA: 
• Female Gender
• Age
• Obesity
• Previous Knee Injury and Overuse
Clinical Manifestations: 
• Chronic Progressive Knee Pain
• Joint Swelling
• Crepitation with Range of Motion
Diagnosis:
• Positive History
• Aspirate Fluid Examination
• Imaging: X-ray showing:
• Joint space narrowing
• Osteophyte formation
Current Treatment Modalities: 
• Lifestyle changes:
• Weight loss
• Lower Extremity Strengthening
• Weight-Bearing Exercise Programs/Classes
• Acetaminophen/NSAIDS
• Intra-articular Injections
• Corticosteroids
• Hyaluronic Acid
• Surgery
• Total Knee Replacement
Background
The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee 
Osteoarthritis: A Meta-analysis of Evidence Level 1
Saltzman et al
Databases utilized: 
• PubMed, CINHAL and the Cochrane Database of 
Systematic Reviews
Keywords:
• osteoarthritis, intraarticular injections, saline, 
corticosteroids and hyaluronic acid
*An individual search was also conducted using 
reference lists through primary articles
Primary Inclusion Criteria:
• randomized control trials, systematic reviews, 
retrospective cohort studies and meta analyses of 
randomized control trials within the past 20 years 
including primary  
Primary Exclusion criteria:
• observational studies, clinical review papers and 
abstracts. 
Terms from PubMed Search
Osteoarthritis AND saline AND corticosteroids AND 
intraarticular injections
Osteoarthritis AND intraarticular injections
Osteoarthritis AND pain AND saline
Intraarticular injections AND corticosteroids AND 
saline
Search dates include: June 2018- August 2018.
Methods
There are serious limitations and high bias risk with the Saltzman et al report, though interesting discussion 
of the placebo effect is addressed in terms of interpreting data collected. This meta-analysis was the first to 
address on a systematic level the comparative effects of normal saline injections as a possible treatment as 
opposed to a control placebo. Taking this into account, limited data and comparison models were available 
to effectively compare these two treatment options at a level of high validity.
McAlindon et al report, was the first of its kind in terms of trialing primary outcomes towards the therapeutic 
effects of normal saline in comparison to corticosteroids. A great deal of effort was made in the set up and 
follow through of this trial to address any concerns of bias and present outcomes in the most reliable 
unbiased way. This report showed variance of clinically indistinguishable analgesic affect, or straight 
superiority of normal saline in this regard depending on the follow up time evaluated through the two years of 
the trial. One area not addressed was the placebo effect, which was thoroughly addressed in Saltzman et al 
report. Despite this, there is low risk of bias, and any perceived biases were properly managed through the 
set-up of the trial as well as through follow up and self-reported variances to the original plan. 
Discussion
The administration of IA placebo saline yields a statistically and meaningful improvement in regard to 
analgesic effect and has shown to be non-inferior to corticosteroids over three months to two years in time. 
Due to the small population of comparative studies available, more data needs to be collected to confirm this 
outcome. Additionally, further trials are necessary to compare IA saline to other treatment modalities, such as 
hyaluronate, PRP and morphine based intra-articular solutions. 
Secondary outcomes also need to be further investigated including progression of disease through cartilage 
degradation, joint space narrowing and overall functionality. 
Conclusions
Results
Figure 1. Osteoarthritis Pathophysiology1
Figure 2. Knee OA Clinical Manifestations1
Role of Intra-Articular Injections
Intraarticular injections have been shown to be the most 
effective non-surgical treatment modality in reducing pain for 
those affected with moderate to severe knee osteoarthritis. 
Clinical use of intra-articular injections dates back to the 
1930s, with widespread and consistent use of the technique 
beginning in the 1950s when intra-articular injections of 
corticosteroids became common for treating patients with 
rheumatoid arthritis (RA). More recently, the use of intra-
articular injections has expanded greatly with the approval 
of hyaluronic acid based injections  as second line treatment 
for moderate to severe OA. Other injectable formulas are 
also being studied, including plasma rich protein (PRP) 
based solutions and morphine based solutions. One of the 
primary goals in the newer formulations is aimed at reducing 
side effects seen with more commonly used corticosteroid 
solutions. The biggest side effect studied in intra-articular 
corticosteroid based treatment is progression of cartilage 
degradation and subsequent joint space narrowing. Despite 
the fact that corticosteroid based injections offer only 
supportive analgesic outcomes without focusing on slowing, 
stopping or reversing the disease process, the steroid 
based injectable solutions remain the first line option for 
patients with osteoarthritis.3Figure 3. Intra-articular Injections1
Normal Saline Intra-Articular Injections 
More recently, studies have been conducted to evaluate many of these newer treatment modalities in 
comparison to the traditionally used steroid based injections. Intra-articular normal saline has been used in 
these more recent studies as a “placebo” medication, with intent to better blind study participants and 
eliminate bias for more reliable outcome data. However, many of these preliminary studies have shown 
outcomes indicating these “placebo” normal saline intra-articular injections may have a therapeutic effect that 
was not before seen or understood.4
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Primary articles were evaluated via Cochrane risk of bias tool and the GRADE assessment tool for validity
Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume 
and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial
McAlidon et al
Double blinded randomized control trial investigating intraarticular (IA) 
injections of triamcinolone, 40mg every 3 months, to IA saline (0.9% 
sodium chloride) over a two-year period.
Primary outcomes were cartilage loss, articular structure damage, 
pain and physical function. Inclusion criteria: age greater than 45 and 
a diagnosis of knee osteoarthritis as defined by the American College 
of Rheumatology classification criteria (come back to cite this).
140 participants separated into two arms: triamcinolone and IA saline 
groups every three months for 2 years. Characteristics of each group 
can be seen in Table 3. 
Initial results did not show a significant different across the two 
treatment groups. −1.2 units (on WOMAC 0-20 pain assessment 
scale) in the triamcinolone vs −1.9 in the saline group; between-group 
mean difference: −0.64 (95% CI, −1.6 to 0.29) as illustrated in the 
table below (see Table 4).
Final conclusion discussed from this trial by the authors stated that IA 
saline was non-inferior to triamcinolone in regards to analgesic effects 
over the two year period and was thus, in that regard, showing no 
increased benefit of using corticosteroids over saline for treatment.6
Retrospective meta-analysis of level 1 studies looking at the placebo-controlled trials of injection therapy for 
knee OA between 2006 and 2016. Primary outcomes measured were subjective pain scores assessed via 
Visual Analog Scale (VAS) for pain and the WOMAC pain assessment.
14 placebo cohorts in 13 studies analyzed included 1076 placebo control patients.
Only sufficient evidence for VAS pain and WOMAC total scores at 3 and 6 months, which came from 4 of the 
13 studies. These values were compared to changes seen in pain scores from trials with corticosteroid 
injections, taking into account a likely placebo effect.
Calculated change in the VAS pain score (Δ = 16.62 of 100) at 6 months after the injection exceeds the 
published MCID of 13.7, suggesting that IA-NS placebo injections provide a statistically and clinically 
meaningful improvement in knee pain for OA. The calculated change in the WOMAC total score (Δ = 11.34) 
at 6 months after the placebo injection was greater than the published MCID of 9, implying that the placebo 
intervention resulted in a clinically significant improvement as well. Comparing to the corticosteroid injections 
in similar trials, CS injections demonstrated to improve VAS pain from 71.5 to 65.6 (Δ = 5.9 of 100) in three 
months (similar WOMAC scores were not provided). Extrapolated, this would show a superiority of IA normal 
saline above IA corticosteroids for analgesic effects.5
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